Altimmune to participate in the guggenheim smid cap biotech conference

Gaithersburg, md., jan. 29, 2025 (globe newswire) -- altimmune, inc. (nasdaq: alt), a clinical-stage biopharmaceutical company, today announced that members of the company's management team will participate in a fireside chat at the guggenheim smid cap biotech conference. details are as follows:

ALT Ratings Summary

ALT Quant Ranking